Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Onyx Weight Loss

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Onyx Weight Loss head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 316 · Grade C

Onyx Weight Loss

Visit Onyx Weight Loss Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 63 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Onyx Weight Loss a bad call — it's best for readers in onyx’s published service states who want a scheduled clinical consultation rather than choosing solely from an online drug price. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
62
Transparency
90
88
Access Breadth
93
56
Clinical Oversight
92
68
Track Record
88
58
CoreAge RxBrief Score 94 · 63Onyx Weight Loss

Price, coverage & the tracker

CoreAge RxOnyx Weight Loss
Brief Score94/100 (A)63/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Current medication quote unconfirmed

Current public offer describes GLP-1 care without an exact semaglutide preparation. Earlier $228/month starting-dose compounded listing is historical.

Nine listed telehealth states. Obtain selected prescription, full charge, appointment policy and pharmacy-order cancellation terms.

Full price details

Current semaglutide preparation and complete quote unknown; public site describes GLP-1 care without a current molecule-specific offer; earlier $228/month starting-dose compounded listing is historical

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Current medication quote unconfirmed

Current public offer describes GLP-1/GIP care without an exact tirzepatide preparation. Earlier $280/month starting-dose compounded listing is historical.

Generic oral alternatives do not establish oral GLP-1 availability. Confirm treatment-specific eligibility, medication and care costs.

Full price details

Current tirzepatide preparation and complete quote unknown; public site describes GLP-1/GIP care without a current molecule-specific offer; earlier $280/month starting-dose compounded listing is historical

CoverageUS only; restrictions by state, confirmed at intakePublished telehealth states: CO, IA, ME, NE, NH, NC, PA, VT and VA; treatment-specific eligibility requires confirmation
Brand-name accessNot confirmedCurrent reviewed service pages do not establish a named branded GLP-1 prescribing offer; confirm the actual prescription.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Onyx Weight Loss: Current care spans nine listed states; exact medication preparation and quote remain unconfirmed. Earlier $228/$280 monthly observations are historical. Obtain appointment and prescription-specific payment terms.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.